Insulet (PODD) Income from Continuing Operations (2010 - 2026)
Insulet (PODD) reported Income from Continuing Operations of 91100000.0 for Q1 2026, up 156.62% on a YoY basis from 35500000.0 in Q1 2025, and down 10.42% quarter-over-quarter from 101700000.0 in Q4 2025.
Insulet (PODD) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Insulet has reported Income from Continuing Operations for 17 years, with the latest figure at 91100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 156.62% year-over-year to 91100000.0; the trailing twelve-month figure through Mar 2026 stood at 302900000.0 (down 24.71% YoY), and the FY2025 full-year result was 247100000.0, down 40.93% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 91100000.0, down from 101700000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 188600000.0 in Q2 2024, with the low at 35000000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 56923529.41 across 5 years, with a median of 51500000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 141.27% — and 2023, when it surged 1098.08%.
- Insulet's Income from Continuing Operations stood at 17000000.0 in 2022, then jumped by 508.24% to 103400000.0 in 2023, then retreated by 2.61% to 100700000.0 in 2024, then advanced by 0.99% to 101700000.0 in 2025, then decreased by 10.42% to 91100000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 91100000.0 (Q1 2026), 101700000.0 (Q4 2025), and 87600000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | 91.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.10 Mn |
| Dec 31, 2025 | 101.70 Mn |
| Sep 30, 2025 | 87.60 Mn |
| Jun 30, 2025 | 22.50 Mn |
| Mar 31, 2025 | 35.50 Mn |
| Dec 31, 2024 | 100.70 Mn |
| Sep 30, 2024 | 77.50 Mn |
| Jun 30, 2024 | 188.60 Mn |
| Mar 31, 2024 | 51.50 Mn |
| Dec 31, 2023 | 103.40 Mn |
| Sep 30, 2023 | 51.90 Mn |
| Jun 30, 2023 | 27.30 Mn |
| Mar 31, 2023 | 23.80 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -35.00 Mn |
| Mar 31, 2022 | 27.80 Mn |
| Dec 31, 2021 | 29.20 Mn |
| Sep 30, 2021 | 12.60 Mn |
| Jun 30, 2021 | -25.00 Mn |